浙江医学
浙江醫學
절강의학
ZHEJIANG MEDICAL JOURNAL
2013年
23期
2047-2049,2079
,共4页
杨勇明%崔健%丁丽君%王建江%阮华娟%方亚平
楊勇明%崔健%丁麗君%王建江%阮華娟%方亞平
양용명%최건%정려군%왕건강%원화연%방아평
胃肿瘤%Beclin1基因%MAPLC3基因
胃腫瘤%Beclin1基因%MAPLC3基因
위종류%Beclin1기인%MAPLC3기인
Gastric cancer%Beclin1%MAPLC3
目的:探讨胃癌组织中自噬相关蛋白Beclin1与微管相关蛋白轻链3(MAPLC3)的表达及其临床意义。方法采用免疫组化En- Vision法检测59例胃癌组织和相应的癌旁组织中Beclin1及MAPLC3的表达水平,分析其与多种胃癌临床病理参数之间的关系。结果在胃癌组织中Beclin1和MAPLC3的阳性表达率分别为40.7%和44.1%,癌旁组织的阳性表达率分别为100%、93.2%,癌组织明显低于癌旁组织(P<0.05);Beclin1和MAPLC3的表达水平与胃癌的浸润深度、淋巴结转移及TNM分期相关(P<0.05);胃癌组织中Beclin1和MAPLC3的表达水平呈正相关(r=0.425,P<0.05)。结论胃癌组织中Beclin1和MAPLC3表达水平均明显低于癌旁组织,且两者之间呈正相关,两者的低表达可能共同促进胃癌的淋巴结转移。
目的:探討胃癌組織中自噬相關蛋白Beclin1與微管相關蛋白輕鏈3(MAPLC3)的錶達及其臨床意義。方法採用免疫組化En- Vision法檢測59例胃癌組織和相應的癌徬組織中Beclin1及MAPLC3的錶達水平,分析其與多種胃癌臨床病理參數之間的關繫。結果在胃癌組織中Beclin1和MAPLC3的暘性錶達率分彆為40.7%和44.1%,癌徬組織的暘性錶達率分彆為100%、93.2%,癌組織明顯低于癌徬組織(P<0.05);Beclin1和MAPLC3的錶達水平與胃癌的浸潤深度、淋巴結轉移及TNM分期相關(P<0.05);胃癌組織中Beclin1和MAPLC3的錶達水平呈正相關(r=0.425,P<0.05)。結論胃癌組織中Beclin1和MAPLC3錶達水平均明顯低于癌徬組織,且兩者之間呈正相關,兩者的低錶達可能共同促進胃癌的淋巴結轉移。
목적:탐토위암조직중자서상관단백Beclin1여미관상관단백경련3(MAPLC3)적표체급기림상의의。방법채용면역조화En- Vision법검측59례위암조직화상응적암방조직중Beclin1급MAPLC3적표체수평,분석기여다충위암림상병리삼수지간적관계。결과재위암조직중Beclin1화MAPLC3적양성표체솔분별위40.7%화44.1%,암방조직적양성표체솔분별위100%、93.2%,암조직명현저우암방조직(P<0.05);Beclin1화MAPLC3적표체수평여위암적침윤심도、림파결전이급TNM분기상관(P<0.05);위암조직중Beclin1화MAPLC3적표체수평정정상관(r=0.425,P<0.05)。결론위암조직중Beclin1화MAPLC3표체수평균명현저우암방조직,차량자지간정정상관,량자적저표체가능공동촉진위암적림파결전이。
Objective To investigate the expression of Beclin1 and MAPLC3 in gastric cancer and clinical significance. Methods Immunohistochemical assay was performed to detect the expression of Beclin1 and MAPLC3 in fifty- nine gastric carci-noma tissues and their adjacent noncancerous specimens. Results (1) The expression of Beclin1 and MAPLC3 was both de-creased in carcinoma tissues(24/59, 40.7%and 26/59, 44.1%), which were significantly lower than those in noncancerous tissues (P<0.05).(2)The expression of both Beclin1 and MAPLC3 was correlated with depth of invasion, lymph node metastasis and TNM classification (P<0.05).(3) There was positive correlation between the expression of Beclin1 and MAPLC3 (r=0.425, P<0.05). Conclusion The expression of Beclin1 and MAPLC3 both reduced in gastric carcinoma tissues, and the downregulation of Beclin1 is significantly associated with MAPLC3. The co- downregulation of Beclin1 and MAPLC3 may play an important role in lymphatic spread of gastric carcinoma.